Antibody shows promise in 5 kinds of childhood brain cancer

Stanford researchers have found that a recently developed antibody reduced the size of five different types of tumors in mouse models of childhood brain cancer. The treatment, dubbed Hu5F9-G4, also specifically targeted malignant cells, sparing healthy tissue.